Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission-Reference-Cited by-同舟云学术

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

Published:2014-08-15 Issue:3 Volume:232 Page:605-621
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Snyder Gretchen L.,Vanover Kimberly E.,Zhu Hongwen,Miller Diane B.,O’Callaghan James P.,Tomesch John,Li Peng,Zhang Qiang,Krishnan Vaishnav,Hendrick Joseph P.,Nestler Eric J.,Davis Robert E.,Wennogle Lawrence P.,Mates Sharon

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s00213-014-3704-1/fulltext.html

Reference66 articles.

1. Alimohamad H, Rajakumar N, Seah YH, Rushlow W (2005) Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol Psychiatry 57:533–42

2. Ancoli-Israel S, Vanover KE, Weiner DM, Davis RE, van Kammen DP (2011) Pimavanserin tartrate, a 5-HT(2A) receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers. Sleep Med 12:134–141

3. Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin J-P (2004) 5-HT2A and α1b-adrenergic receptors entirely mediate dopamine release, locomotor response, and behavioral sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073–3084

4. Beaulieu J-M, Gainetdinov RR, Caron MG (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327–347

5. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggeia DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864–8

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signal-On Detection of Dopamine and Tyrosinase Using Tris(hydroxypropyl)phosphine as a New Lucigenin Chemiluminescence Coreactant;Analytical Chemistry;2024-09-05

2. Clinical Pipelines for Alzheimer’s Disease Psychosis and Agitation;Chemical and Pharmaceutical Bulletin;2024-07-01

3. LUMATEPERONE;Prescriber's Guide;2024-04-18

4. Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data;European Neuropsychopharmacology;2024-04

5. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024